Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Without therapy HLH is often fatal, and often rapidly fatal. The treatment protocol HLH-94
has improved survival markedly as compared to the survival earlier. We now aim to improve
survival further.
Phase:
Phase 3
Details
Lead Sponsor:
Karolinska University Hospital
Collaborators:
Azienda Ospedaliero, Universitaria Meyer Baylor College of Medicine Children's Hospital Medical Center, Cincinnati Ehime University Graduate School of Medicine Great Ormond Street Hospital for Children NHS Foundation Trust Hospital de Cruces Hospital JP Garrahan Leiden University Medical Center St. Anna Kinderkrebsforschung Texas Children's Hospital Universitätsklinikum Hamburg-Eppendorf